 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW . 
        [Brackets ] indicate matter deleted from existing law.  
         Underlining  indicates amendments to bill.  
         Strike out  indicates matter stricken from the bill by amendment or deleted from the law by 
amendment.             *hb1004*      
HOUSE BILL 1004  
J1   5lr2242  
    CF SB 748  
By: Delegate Martinez  Delegates Martinez, Alston, Bagnall, Bhandari, Cullison, 
Guzzone, Hill, Hutchinson, S.  Johnson, Kaiser, Kerr, Kipke, Lopez,  
Pena –Melnyk, Reilly, Rosenberg, Ross, Taveras, White  Holland, Woods, and 
Woorman  
Introduced and read first time: January 31, 2025  
Assigned to: Health and Government Operations  
Committee Report: Favorable with amendments  
House action: Adopted  
Read second time: March 6, 2025  
 
CHAPTER ______  
 
AN ACT concerning  1 
 
Public Health – Alzheimer’s Disease and Related Dementias – Information on 2 
Prevalence and Treatment  3 
 
FOR the purpose of requiring the Maryland Department of Health, in partnership with 4 
certain entities, to incorporate information regarding treatments approved by the 5 
Food and Drug Administration for Alzheimer’s di sease and related dementias and to 6 
increase understanding and awareness of treatment of Alzheimer’s disease and 7 
related dementias into relevant public health outreach programs administered by 8 
the Department; requiring the Department to establish and mainta in a website that 9 
includes certain information on the prevalence and hospitalization rate of 10 
Alzheimer’s disease and related dementias; and generally related to Alzheimer’s 11 
disease and related dementias.  12 
 
BY repealing and reenacting, with amendments,  13 
 Article – Health – General  14 
Section 18 –110 15 
 Annotated Code of Maryland  16 
 (2023 Replacement Volume and 2024 Supplement)  17 
 
BY adding to  18 
 Article – Health – General  19 
Section 18 –111 20 
2 HOUSE BILL 1004   
 
  Annotated Code of Maryland  1 
 (2023 Replacement Volume and 2024 Supplement)  2 
 
 SECTION  1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 3 
That the Laws of Maryland read as follows:  4 
 
Article – Health – General  5 
 
18–110. 6 
 
 The Department, in partnership with the Department of Aging, the Virginia I. Jones 7 
Alzheimer’s Disease and Related Disorders  DEMENTIAS  Council, and the Greater 8 
Maryland Chapter of the Alzheimer’s Association, shall incorporate information into 9 
relevant public health outreach programs administered by the Department to:  10 
 
  (1) Educate health care providers regarding:  11 
 
   (i) The importance of early detection and timely diagnosis of 12 
cognitive impairment;  13 
 
   (ii) Validated assessment tools for the detection and diagnosis of 14 
cognitive impairment;  15 
 
   (iii) The value of a Medicare annual wellness visit or other annual 16 
physical f or an individual at least 65 years old for cognitive health; [and] 17 
 
   (iv) The Medicare care planning billing code for individuals with 18 
cognitive impairment; and  19 
 
   (V) TREATMENTS APPROVED B Y THE FOOD AND DRUG 20 
ADMINISTRATION FOR ALZHEIMER ’S DISEASE AND R ELATED DEMENTIAS , 21 
INCLUDING RELEVANT I NFORMATION ON TREATM ENT USE AND OUTCOMES ; AND  22 
 
  (2) Increase PUBLIC  understanding and awareness of:  23 
 
   (i) The early warning signs of Alzheimer’s disease and [other types 24 
of dementia ] RELATED DEMENTIAS ; 25 
 
   (ii) The value of early detection [and], diagnosis , AND TREATMENT  26 
of Alzheimer’s disease and [other types of dementia ] RELATED DEMENTIAS ; and 27 
 
   (iii) How to reduce the risk of cognitive decline, particularly among 28 
individuals in Black and Latino communities who are at greater risk of developing 29 
Alzheimer’s disease and [other types of dementia ] RELATED DEMENTIAS ; AND 30 
 
 HOUSE BILL 1004  3 
 
    (IV) TREATMENTS APPROVED B Y THE U.S. FOOD AND DRUG 1 
ADMINISTRATION FOR ALZHEIMER ’S DISEASE AND RELATE D DEMENTIAS AND 2 
RELEVANT INFORMATION  ON TREATMENT USE AND  OUTCOMES , INCLUDING 3 
INFORMATION RELATED TO TREATMENT OUTCOME S BASED ON BIOLOGICA L SEX . 4 
 
18–111. 5 
 
 (A) THE DEPARTMENT , IN COLLABORATION WITH T HE STATE –DESIGNATED 6 
HEALTH INFORMATION E XCHANGE , SHALL ESTABLISH AND MAINTAIN A PUBLICLY 7 
ACCESSIBLE WEBSITE T HAT INCLUDES IN A DO WNLOADABLE FORMAT TH E 8 
FOLLOWING INFORMATIO N: 9 
 
  (1) THE PREVALENCE OF ALZHEIMER ’S DISEASE AND RELATE D 10 
DEMEN TIAS IN THE STATE ; 11 
 
  (2) THE HOSPITALIZATION R ATE RELATED TO ALZHEIMER ’S DISEASE 12 
AND RELATED DEMENTIA S; AND 13 
 
  (3) TO THE EXTENT POSSIBL E, THE PREVALENCE AND 14 
HOSPITALIZATION RATE  OF ALZHEIMER ’S DISEASE AND RELATE D DEMENTIAS 15 
DISAGGREGATED BASED ON: 16 
 
   (I) AGE, INCLUDING AGE OF DIA GNOSIS ; 17 
 
   (II) SEX; 18 
 
   (III) RACE; 19 
 
   (IV) ETHNICITY ; AND  20 
 
   (V) NUMBER OF CASES BY CO UNTY ;  21 
 
   (VI) CO–OCCURRENCE OF DOWN SYNDROME (TRISOMY –21);  22 
AND 23 
 
   (VII) TYPE OF DEMENTIA . 24 
 
 (B) THE WEBSITE REQUIRED UNDER SUBSECTION (A) OF THIS SECTION 25 
SHALL : 26 
 
  (1) INCLUDE THE DATA AVAI LABLE FOR THE IMMEDI ATELY 27 
PRECEDING 5–YEAR PERIOD ENDING SEPTEMBER 30, 2025;  AND 28 
 
4 HOUSE BILL 1004   
 
   (2) BE UPDATED ON OR BEFO RE JANUARY 1 EACH YEAR , BEGINNING 1 
IN 2027,  TO INCLUDE ANY NEWLY  AVAILABLE DATA . 2 
 
 SECTION 2.  AND BE IT FURTHER ENACTED, That this Act shall take effect 3 
October 1, 2025.  4 
 
 
 
 
Approved:  
________________________________ ________________________________ ________________   
           Governor.  
________________________________ ________________________________ ________________   
         Speaker of the House of Delegates.  
________________________________ ________________________________ ________________   
                 President of the Senate.  